Dermira Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Dermira Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					             Dermira Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH358377D                                                                                                              Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Dermira Inc. (Dermira) is a development-stage biotechnology company. It focuses
                                                                                                              Dermira Inc., Pharmaceuticals & Healthcare, Key
      on developing and commercializing novel therapies for the dermatology diseases.
                                                                                                              Facts
      The company owns and licenses a pipeline of new topical compounds addressing
      the unmet medical needs in dermatology. Dermira uses innovative science to                               Web Address                            www.dermira.com
      advance therapeutics in dermatology.
                                                                                                               Revenue (US$ million)                                 NA
                                                                                                               Number of Employees                                   NA
                                                                                                               GlobalData

      Financial Deals Landscape
        Dermira Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007                   Dermira Inc., Pharmaceuticals & Healthcare, Deals By Year,
        to YTD 2013                                                                       2007 to YTD 2013


                                                                                                                                            3
                                                                                                          3




                                                                                           No. of Deals
                                                                                                                                                      2
                                                                                                          2

                                                                                                                                                           1
                                                                                                          1

                                                                                                                 0         0       0                                  0
                                                                                                          0
                                                                                                               2007       2008   2009      2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Dermira Inc., Pharmaceuticals & Healthcare, Deals By                             Dermira Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         8                                                                                8
                               6                                                                                      6
          No. of Deals




                                                                                           No. of Deals




                         6                                                                                6

                         4                                                                                4

                         2                                                                                2
                                        0         0        0         0                                                                 0          0              0
                         0                                                                                0
                             North    Asia-     Europe   Middle   South                                          Dermatol        Cardiova       Central   Pharmac
                             Americ   Pacific             East     and                                             ogy            scular        Nervous    euticals
                               a                          and     Central                                                                       System       and
                                                         Africa   Americ                                                                                  Healthcar
                                                                    a                                                                                         e



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Dermira Inc. - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                 Reference Code: GDPH358377D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Dermira Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .............................................................................. 3
       Dermira Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013............................................................................... 5
       Dermira Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .......................................................................... 6
       Dermira Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................................ 7
       Dermira Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................................... 8
       Dermira Inc., Pharmaceuticals & Healthcare, Deal Details................................................................................................................. 9
          Asset Purchase............................................................................................................................................................................... 9
             Valocor Therapeutics Acquires Rights To Novel Dermatology Programs From QLT .................................................................. 9
          Venture Financing......................................................................................................................................................................... 11
             Dermira Raises $34 Million In Venture Financing ..................................................................................................................... 11
             Dermira Secures $42 Million In Series A Financing .................................................................................................................. 13
             Dermira Raises Seed Financing From Bay City Capital ............................................................................................................ 15
             Valocor Therapeutics Secures Seed Financing ........................................................................................................................ 16
          Acquisition .................................................................................................................................................................................... 17
             Dermira Acquires Valocor Therapeutics .................................................................................................................................... 17
       Dermira Inc. - Key Competitors ........................................................................................................................................................ 19
       Key Employees ..............................................................................
				
DOCUMENT INFO
Description: Dermira Inc. (Dermira) is a development-stage biotechnology company. It focuses on developing and commercializing novel therapies for the dermatology diseases. The company owns and licenses a pipeline of new topical compounds addressing the unmet medical needs in dermatology. Dermira uses innovative science to advance therapeutics in dermatology. The company’s product portfolio includes its most advanced compound, lemuteporfin, a potent and selective topical photodynamic therapy in Phase I trials for the treatment of sebaceous gland disorders, including acne; DRM01, a sebum inhibitor in preclinical trials for the treatment of acne; DRM02, a kinase inhibitor for the treatment of inflammatory skin diseases. Dermira is headquartered in Redwood City, California, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.